Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBOT | PHAT | PCRX | ||
| Company | Bridgebio Oncology Therapeutics Inc | Phathom Pharmaceuticals Inc | Pacira Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.05 | 15.03 | 23.98 | ||
| High | 13.07 | 15.14 | 24.79 | ||
| Low | 12.64 | 14.45 | 23.98 | ||
| Latest | 12.62 | 14.54 | 24.84 | ||
| Change | -0.52 | -0.36 | +0.42 | ||
| % Change | -3.96% | -2.42% | +1.72% | ||
| Volume | 64,874 | 267,751 | 176,878 | ||
| 20-Day Average Volume | 165,529 | 802,520 | 642,061 | ||
| Previous Close | 13.14 | 14.90 | 24.42 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.51 | 14.78 | 23.83 | ||
| 20-Day Raw Stochastic | 47.97% | 35.35% | 93.05% | ||
| 20-Day Relative Strength | 53.43 | 55.44 | 58.54 | ||
| Weighted Alpha | +23.06 | +33.27 | +19.32 | ||
| Today's Opinion | 96% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | 96% Buy | 100% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.81% since 12/02/25 | -0.51% since 12/02/25 | +2.89% since 12/02/25 | ||
| Low | 10.68 on 12/03/25 | 14.12 on 12/05/25 | 23.63 on 12/08/25 | ||
| High | 14.87 on 12/08/25 | 15.16 on 12/03/25 | 24.81 on 12/03/25 | ||
| 1-Month | |||||
| %Chg | +4.44% since 11/07/25 | +10.68% since 11/07/25 | +12.31% since 11/07/25 | ||
| Low | 10.68 on 12/03/25 | 13.40 on 11/10/25 | 21.67 on 11/10/25 | ||
| High | 14.87 on 12/08/25 | 16.26 on 11/28/25 | 24.95 on 11/20/25 | ||
| 3-Month | |||||
| %Chg | +24.05% since 09/09/25 | +13.77% since 09/09/25 | -5.84% since 09/09/25 | ||
| Low | 9.50 on 09/15/25 | 10.33 on 10/07/25 | 19.84 on 10/21/25 | ||
| High | 14.87 on 12/08/25 | 16.26 on 11/28/25 | 27.50 on 09/15/25 | ||
| 6-Month | |||||
| %Chg | +16.64% since 06/09/25 | +66.08% since 06/09/25 | -2.58% since 06/09/25 | ||
| Low | 8.50 on 08/05/25 | 7.61 on 07/22/25 | 19.84 on 10/21/25 | ||
| High | 14.87 on 12/08/25 | 16.26 on 11/28/25 | 27.64 on 09/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,051,055 | 1,059,956 | 1,050,573 | ||
| Shares Outstanding, K | 79,989 | 71,138 | 43,021 | ||
| Annual Sales | 0 | 55,250,000 | 700,970,000 | ||
| Annual Net Income | -74,275,000 | -334,330,000 | -99,560,000 | ||
| Last Quarter Sales | 0 | 49,500,000 | 179,520,000 | ||
| Last Quarter Net Income | -44,757,000 | -29,970,000 | 5,430,000 | ||
| 60-Month Beta | 0.12 | 0.43 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/12/25 | -0.15 on 10/30/25 | 0.70 on 11/06/25 | ||
| Latest Earnings Date | N/A | 10/30/25 | 11/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 11.82 | ||